In view of the recognized importance of the NLRP3 pathway in particle-induced diseases, such as MWCNT-induced lung fibrosis, we propose to use our approach as an early in vitro screening tool when assessing the hazard of particles, fibers, and MNPs in a hierarchical testing strategy. Here, NLRP3 is linked to pulmonary fibrosis.